Same as ever14 Dec 2023 07:16
"The Phase 1a clinical trial, evaluating SDC-1801 in healthy subjects, commenced in May 2023 at a specialist clinical unit in Melbourne, Australia.
",,,,the Company plans to initiate a Phase 1b clinical study, aiming to recruit up to 24 psoriasis patients. This study is expected to be completed before the end of 2024"
First a clinical trial and now a clinical study (the difference being??) taking us on another 12 months. Always jam tomorrow as per the last decade.
Then, despite encouraging noises last December 737 still dead in the water.
Yawn.